Blog
Intuit & 2 Other Strong Buy Profitable Stocks for Your Portfolio
Investors should prioritize profitable companies over loss-making ones to ensure solid returns after covering all costs. We have used accounting ratios to evaluate a company’s profitability. There
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?
Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus (HPV). Though the vaccine’s sales rose consistently till 2022
AI Infrastructure Boom: 2 Companies Poised to Benefit
Artificial intelligence (AI) remains among the hottest market topics, with investors continuing to seek ways to obtain exposure. The theme has undoubtedly been the strongest we’ve seen in years
CNI Plans to Invest $85 Million in Michigan for Rail Innovation
Canadian National Railway Company (CNI) is forging ahead with a $85 million investment in Michigan, as part of its 2025 capital investment program, signaling strong confidence in the region’s
Airline Stocks Bounce Back on Monday's Trading: Here's Why
Players in the Zacks Airline industry have made a notable comeback by performing well on the bourses on Monday, June 17, 2025. Industry heavyweights like Delta Air Lines, Inc. (DAL), United Airlines
Are PG's Beauty and Health Units Driving the Next Leg of Growth?
The Procter & Gamble Company PG plays a pivotal role in enhancing health and beauty through its product innovations and purpose-driven corporate social responsibility (CSR) efforts to ensure global
Fifth Third Rewards Shareholders With New Share Repurchase Program
Fifth Third Bancorp's FITB board of directors has approved a new share repurchase authorization of up to 100 million shares.
The new authorization replaces the previous authorization announced in
3 Growth Stocks Exploding Higher Now (OUST, PGY, LGCY)
In a market where momentum has returned with a vengeance, a select group of growth stocks is breaking out with force. While many investors remain focused on the usual mega cap names, under-the-radar
Why Gold ETFs Offer the Best Safe Haven Right Now
Gold has surged to record highs fueled by rising geopolitical tensions, such as Iran-Israel tensions, and a sharp loss of confidence in traditional U.S. safe havens. Historically, investors turned
Here is Why Growth Investors Should Buy Construction Partners (ROAD) Now
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth
Here is Why Growth Investors Should Buy ProDex (PDEX) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
Is Northwest Natural (NWN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth
Lincoln National Debuts Hybrid Growth Fund in Variable Annuities
Lincoln National Corporation LNC recently unveiled LVIP American Funds Vanguard Active Passive Growth Fund, a new investment option offered exclusively within its American Legacy and Lincoln
Is PepsiCo's North America Unit Losing Steam Amid Softening Demand?
PepsiCo, Inc.’s PEP North America unit, particularly its Foods division, is facing notable pressure amid softening consumer demand and persistent macroeconomic challenges. In first-quarter 2025, the
Rio Tinto Secures ARENA Support to Advance Decarbonisation Project
Rio Tinto Group RIO announced that its joint venture NeoSmelt secured Australian Renewable Energy Agency’s (“ARENA”) support for its planned Western Australian pilot plant.
Details on RIO’s Joint
Meta Platforms Adds Ads in WhatsApp: Is it the Next Revenue Pillar?
Meta Platforms META is adding channel subscriptions, promoted channels and ads in Status in the WhatsApp updates tab, which is now used by 1.5 billion people globally. META plans to maintain user
Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy
Teva Pharmaceutical TEVA announced that it has entered into a strategic collaboration agreement with China-based Fosun Pharmaceutical to codevelop TEV-56278, an anti-PD1-IL2 ATTENUKINE therapy.
ET Stock Outperforms its Industry in Nine Months: How to Play?
Units of Energy Transfer LP ET have rallied 12.2% in the past nine months compared with the Zacks Oil and Gas - Production Pipeline - MLB industry’s growth of 4.8%. The oil and gas midstream company






